Skip to main content
PMC home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1989 Oct;45(4):507–520.

Molecular and phenotypic analysis of patients with deletions within the deletion-rich region of the duchenne muscular dystrophy (DMD) gene

E F Gillard, J S Chamberlain, E G Murphy, C L Duff, B Smith, A H M Burghes, M W Thompson, J Sutherland, I Oss, S E Bodrug, H J Klamut, P N Ray, R G Worton
PMCID: PMC1683502  PMID: 2491010

Abstract

Eighty unrelated individuals with Duchenne muscular dystrophy (DMD) or Becker muscular dystrophy (BMD) were found to have deletions in the major deletion-rich region of the DMD locus. This region includes the last five exons detected by cDNA5b–7, all exons detected by cDNA8, and the first two exons detected by cDNA9. These 80 individuals account for approximately 75% of 109 deletions of the gene, detected among 181 patients analyzed with the entire dystrophin cDNA. Endpoints for many of these deletions were further characterized using two genomic probes, p20 (DXS269; Wapenaar et al.) and GMGX11 (DXS239; present paper). Clinical findings are presented for all 80 patients allowing a correlation of phenotypic severity with the genotype. Thirty-eight independent patients were old enough to be classified as DMD, BMD, or intermediate phenotype and had deletions of exons with sequenced intron/exon boundaries. Of these, eight BMD patients and one intermediate patient had gene deletions predicted to leave the reading frame intact, while 21 DMD patients, 7 intermediate patients, and 1 BMD patient had gene deletions predicted to disrupt the reading frame. Thus, with two exceptions, frameshift deletions of the gene resulted in more severe phenotype than did in-frame deletions. This is in agreement with recent findings by Baumbach et al. and Koenig et al. but is in contrast to findings, by Malhotra et al., at the 5' end of the gene.

Full text

PDF
507

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anand R., Boehm C. D., Kazazian H. H., Jr, Vanin E. F. Molecular characterization of a beta zero-thalassemia resulting from a 1.4 kilobase deletion. Blood. 1988 Aug;72(2):636–641. [PubMed] [Google Scholar]
  2. Baumbach L. L., Chamberlain J. S., Ward P. A., Farwell N. J., Caskey C. T. Molecular and clinical correlations of deletions leading to Duchenne and Becker muscular dystrophies. Neurology. 1989 Apr;39(4):465–474. doi: 10.1212/wnl.39.4.465. [DOI] [PubMed] [Google Scholar]
  3. Boyd Y., Cockburn D., Holt S., Munro E., Van Ommen G. J., Gillard B., Affara N., Ferguson-Smith M., Craig I. Mapping of 12 translocation breakpoints in the Xp21 region with respect to the locus for Duchenne muscular dystrophy. Cytogenet Cell Genet. 1988;48(1):28–34. doi: 10.1159/000132581. [DOI] [PubMed] [Google Scholar]
  4. Burghes A. H., Logan C., Hu X., Belfall B., Worton R. G., Ray P. N. A cDNA clone from the Duchenne/Becker muscular dystrophy gene. 1987 Jul 30-Aug 5Nature. 328(6129):434–437. doi: 10.1038/328434a0. [DOI] [PubMed] [Google Scholar]
  5. Burmeister M., Monaco A. P., Gillard E. F., van Ommen G. J., Affara N. A., Ferguson-Smith M. A., Kunkel L. M., Lehrach H. A 10-megabase physical map of human Xp21, including the Duchenne muscular dystrophy gene. Genomics. 1988 Apr;2(3):189–202. doi: 10.1016/0888-7543(88)90002-x. [DOI] [PubMed] [Google Scholar]
  6. Chamberlain J. S., Gibbs R. A., Ranier J. E., Nguyen P. N., Caskey C. T. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res. 1988 Dec 9;16(23):11141–11156. doi: 10.1093/nar/16.23.11141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cross S. H., Little P. F. A cosmid vector for systematic chromosome walking. Gene. 1986;49(1):9–22. doi: 10.1016/0378-1119(86)90381-1. [DOI] [PubMed] [Google Scholar]
  8. Darras B. T., Blattner P., Harper J. F., Spiro A. J., Alter S., Francke U. Intragenic deletions in 21 Duchenne muscular dystrophy (DMD)/Becker muscular dystrophy (BMD) families studied with the dystrophin cDNA: location of breakpoints on HindIII and BglII exon-containing fragment maps, meiotic and mitotic origin of the mutations. Am J Hum Genet. 1988 Nov;43(5):620–629. [PMC free article] [PubMed] [Google Scholar]
  9. Darras B. T., Francke U. Normal human genomic restriction-fragment patterns and polymorphisms revealed by hybridization with the entire dystrophin cDNA. Am J Hum Genet. 1988 Nov;43(5):612–619. [PMC free article] [PubMed] [Google Scholar]
  10. Feinberg A. P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983 Jul 1;132(1):6–13. doi: 10.1016/0003-2697(83)90418-9. [DOI] [PubMed] [Google Scholar]
  11. Forrest S. M., Cross G. S., Flint T., Speer A., Robson K. J., Davies K. E. Further studies of gene deletions that cause Duchenne and Becker muscular dystrophies. Genomics. 1988 Feb;2(2):109–114. doi: 10.1016/0888-7543(88)90091-2. [DOI] [PubMed] [Google Scholar]
  12. Forrest S. M., Cross G. S., Speer A., Gardner-Medwin D., Burn J., Davies K. E. Preferential deletion of exons in Duchenne and Becker muscular dystrophies. Nature. 1987 Oct 15;329(6140):638–640. doi: 10.1038/329638a0. [DOI] [PubMed] [Google Scholar]
  13. Forrest S. M., Smith T. J., Cross G. S., Read A. P., Thomas N. S., Mountford R. C., Harper P. S., Geirsson R. T., Davies K. E. Effective strategy for prenatal prediction of Duchenne and Becker muscular dystrophy. Lancet. 1987 Dec 5;2(8571):1294–1297. doi: 10.1016/s0140-6736(87)91192-5. [DOI] [PubMed] [Google Scholar]
  14. Gillard E. F., Affara N. A., Yates J. R., Goudie D. R., Lambert J., Aitken D. A., Ferguson-Smith M. A. Deletion of a DNA sequence in eight of nine families with X-linked ichthyosis (steroid sulphatase deficiency). Nucleic Acids Res. 1987 May 26;15(10):3977–3985. doi: 10.1093/nar/15.10.3977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hart K. A., Hodgson S., Walker A., Cole C. G., Johnson L., Dubowitz V., Bobrow M. DNA deletions in mild and severe Becker muscular dystrophy. Hum Genet. 1987 Mar;75(3):281–285. doi: 10.1007/BF00281075. [DOI] [PubMed] [Google Scholar]
  16. Hart K., Cole C., Walker A., Hodgson S., Johnson L., Dubowitz V., Ray P., Worton R., Bobrow M. The screening of Duchenne muscular dystrophy patients for submicroscopic deletions. J Med Genet. 1986 Dec;23(6):516–520. doi: 10.1136/jmg.23.6.516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hu X. Y., Burghes A. H., Bulman D. E., Ray P. N., Worton R. G. Evidence for mutation by unequal sister chromatid exchange in the Duchenne muscular dystrophy gene. Am J Hum Genet. 1989 Jun;44(6):855–863. [PMC free article] [PubMed] [Google Scholar]
  18. Koenig M., Beggs A. H., Moyer M., Scherpf S., Heindrich K., Bettecken T., Meng G., Müller C. R., Lindlöf M., Kaariainen H. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet. 1989 Oct;45(4):498–506. [PMC free article] [PubMed] [Google Scholar]
  19. Koenig M., Hoffman E. P., Bertelson C. J., Monaco A. P., Feener C., Kunkel L. M. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell. 1987 Jul 31;50(3):509–517. doi: 10.1016/0092-8674(87)90504-6. [DOI] [PubMed] [Google Scholar]
  20. Koenig M., Monaco A. P., Kunkel L. M. The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell. 1988 Apr 22;53(2):219–228. doi: 10.1016/0092-8674(88)90383-2. [DOI] [PubMed] [Google Scholar]
  21. Kunkel L. M., Hejtmancik J. F., Caskey C. T., Speer A., Monaco A. P., Middlesworth W., Colletti C. A., Bertelson C., Müller U., Bresnan M. Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature. 1986 Jul 3;322(6074):73–77. doi: 10.1038/322073a0. [DOI] [PubMed] [Google Scholar]
  22. Kunkel L. M., Monaco A. P., Middlesworth W., Ochs H. D., Latt S. A. Specific cloning of DNA fragments absent from the DNA of a male patient with an X chromosome deletion. Proc Natl Acad Sci U S A. 1985 Jul;82(14):4778–4782. doi: 10.1073/pnas.82.14.4778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Lindlöf M., Käriäinen H., van Ommen G. J., de la Chapelle A. Microdeletions in patients with X-linked muscular dystrophy: molecular-clinical correlations. Clin Genet. 1988 Feb;33(2):131–139. doi: 10.1111/j.1399-0004.1988.tb03424.x. [DOI] [PubMed] [Google Scholar]
  24. Malhotra S. B., Hart K. A., Klamut H. J., Thomas N. S., Bodrug S. E., Burghes A. H., Bobrow M., Harper P. S., Thompson M. W., Ray P. N. Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science. 1988 Nov 4;242(4879):755–759. doi: 10.1126/science.3055295. [DOI] [PubMed] [Google Scholar]
  25. Monaco A. P., Bertelson C. J., Colletti-Feener C., Kunkel L. M. Localization and cloning of Xp21 deletion breakpoints involved in muscular dystrophy. Hum Genet. 1987 Mar;75(3):221–227. doi: 10.1007/BF00281063. [DOI] [PubMed] [Google Scholar]
  26. Monaco A. P., Bertelson C. J., Liechti-Gallati S., Moser H., Kunkel L. M. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics. 1988 Jan;2(1):90–95. doi: 10.1016/0888-7543(88)90113-9. [DOI] [PubMed] [Google Scholar]
  27. Monaco A. P., Bertelson C. J., Middlesworth W., Colletti C. A., Aldridge J., Fischbeck K. H., Bartlett R., Pericak-Vance M. A., Roses A. D., Kunkel L. M. Detection of deletions spanning the Duchenne muscular dystrophy locus using a tightly linked DNA segment. 1985 Aug 29-Sep 4Nature. 316(6031):842–845. doi: 10.1038/316842a0. [DOI] [PubMed] [Google Scholar]
  28. Ray P. N., Belfall B., Duff C., Logan C., Kean V., Thompson M. W., Sylvester J. E., Gorski J. L., Schmickel R. D., Worton R. G. Cloning of the breakpoint of an X;21 translocation associated with Duchenne muscular dystrophy. Nature. 1985 Dec 19;318(6047):672–675. doi: 10.1038/318672a0. [DOI] [PubMed] [Google Scholar]
  29. Read A. P., Mountford R. C., Forrest S. M., Kenwrick S. J., Davies K. E., Harris R. Patterns of exon deletions in Duchenne and Becker muscular dystrophy. Hum Genet. 1988 Oct;80(2):152–156. doi: 10.1007/BF00702859. [DOI] [PubMed] [Google Scholar]
  30. Thomas N. S., Ray P. N., Worton R. G., Harper P. S. Molecular deletion analysis in Duchenne muscular dystrophy. J Med Genet. 1986 Dec;23(6):509–515. doi: 10.1136/jmg.23.6.509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Vanin E. F., Henthorn P. S., Kioussis D., Grosveld F., Smithies O. Unexpected relationships between four large deletions in the human beta-globin gene cluster. Cell. 1983 Dec;35(3 Pt 2):701–709. doi: 10.1016/0092-8674(83)90103-4. [DOI] [PubMed] [Google Scholar]
  32. Wapenaar M. C., Kievits T., Hart K. A., Abbs S., Blonden L. A., den Dunnen J. T., Grootscholten P. M., Bakker E., Verellen-Dumoulin C., Bobrow M. A deletion hot spot in the Duchenne muscular dystrophy gene. Genomics. 1988 Feb;2(2):101–108. doi: 10.1016/0888-7543(88)90090-0. [DOI] [PubMed] [Google Scholar]
  33. den Dunnen J. T., Bakker E., Breteler E. G., Pearson P. L., van Ommen G. J. Direct detection of more than 50% of the Duchenne muscular dystrophy mutations by field inversion gels. Nature. 1987 Oct 15;329(6140):640–642. doi: 10.1038/329640a0. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES